March 12, 2020 / 9:46 PM / 19 days ago

BRIEF-Bellicum Reports Q4 Revenue Of $5.1 Mln

March 12 (Reuters) - Bellicum Pharmaceuticals Inc:

* BELLICUM REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE

* BELLICUM PHARMACEUTICALS INC - QTRLY REVENUE $5.1 MILLION VERSUS $312,000

* BELLICUM PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $5.82

* BELLICUM PHARMACEUTICALS INC - MANAGEMENT EXPECTS CASH UTILIZATION OF $55 TO $65 MILLION IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below